Fact CheckerSign in

NCT07479264Completed

A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma

MRI-Based Radiomics and Machine Learning for Preoperative Assessment of Intratumoral Fibrosis and α-Smooth Muscle Actin Expression in Intrahepatic Cholangiocarcinoma

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

The aim of this observational study was to understand the prognostic imaging of the degree of intratumoral fibrosis and intratumoral α-SMA levels in patients with intrahepatic cholangiocarcinoma (ICC). The main questions it aims to answer are: Whether the degree of intratumoral fibrosis and the level of intratumoral α-SMA affect the overall survival and progression-free survival of ICC patients. Participants will be surveyed for survival and tumor recurrence up to 5 years after surgery.

Status (registry)
Completed
Study type
Observational
Enrollment
169 (actual)
First submitted
11 Mar 2026
Start date
1 Jan 2018
Primary completion date
17 Jan 2025
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
NCT number
NCT07479264

What you commit to

  • Study type: Observational
  • Participants enrolled: 169
  • From 1 Jan 2018 to the primary completion date, 17 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients had received radiotherapy, chemotherapy, intervention and other treatments for liver tumors before surgery
  • No upper abdominal Gd-EOB-DTPA-enhanced MRI examination in our center within one month before surgery

Other

  • The tumor sections could not be obtained due to the loss of wax blocks or most of the defects of pathological specimens
  • Poor image quality or incomplete image data

Who the study is looking for

  • Patients who underwent radical resection of liver tumors in our center and obtained surgical specimens;
  • ICC was diagnosed by postoperative pathology

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated Hospital, Sun Yat-sen University
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.